Treatment Guidelines for Pneumonia in Elderly Patients

Introduction to Guidelines

The American Thoracic Society recommends that elderly patients with community-acquired pneumonia receive combination therapy with a β-lactam plus a macrolide, as this regimen provides superior coverage for both typical and atypical pathogens and has been associated with improved mortality outcomes in this high-risk population 1, 2

Elderly patients admitted for non-clinical reasons who would otherwise be treated as outpatients can receive amoxicillin monotherapy 3, 4
All other hospitalized elderly patients require combination therapy due to their inherently higher risk status 1, 2

The preferred regimen for elderly patients hospitalized with non-severe pneumonia is oral amoxicillin 1g three times daily plus a macrolide (azithromycin 500mg on day 1, then 250mg daily; or clarithromycin 500mg twice daily) 3, 4, 1
An alternative regimen is respiratory fluoroquinolone monotherapy (levofloxacin 750mg daily or moxifloxacin 400mg daily) for patients intolerant of β-lactams or macrolides 3, 4, 1

Immediate parenteral antibiotics are mandatory upon diagnosis of severe pneumonia in elderly patients—do not delay for diagnostic testing 5, 3
The preferred regimen for severe pneumonia is IV β-lactam plus either azithromycin or respiratory fluoroquinolone 5, 3, 1, 2

For suspected Pseudomonas aeruginosa, use antipseudomonal β-lactam (piperacillin-tazobactam, cefepime, imipenem, or meropenem) plus ciprofloxacin 400mg IV every 8 hours or levofloxacin 750mg IV daily, plus an aminoglycoside 5, 1
For suspected MRSA, add vancomycin 15mg/kg IV every 8-12 hours (target trough 15-20 mg/mL) or linezolid 600mg IV every 12 hours 1

The standard duration of therapy for uncomplicated pneumonia is 7 days once clinical stability is achieved 5, 6
The duration of therapy for severe microbiologically undefined pneumonia is 10 days 5, 3
The duration of therapy for pneumonia caused by Legionella, Staphylococcus aureus, or Gram-negative enteric bacilli is 14-21 days 5, 6, 1

Switch from IV to oral antibiotics when the patient is hemodynamically stable, clinically improving, afebrile for 24 hours, able to take oral medications, and has normal GI function—typically by day 2-3 5, 6, 1

Never use macrolide monotherapy in areas where pneumococcal macrolide resistance exceeds 25% 1
Administer the first antibiotic dose in the emergency department—delayed administration beyond 8 hours increases 30-day mortality by 20-30% in hospitalized patients 1
Do not automatically escalate to broad-spectrum antibiotics (antipseudomonal agents, anti-MRSA coverage) based solely on age or frailty without documented risk factors 1

Clinical review at 6 weeks is mandatory for all elderly patients, either with their general practitioner or in a hospital clinic 3, 4, 7
Influenza vaccination is recommended for all patients aged over 65 years, as they are at high risk of mortality from influenza or complicating pneumonia 5, 6
Pneumococcal vaccination is recommended for all elderly patients, though evidence for preventing CAP in this population is limited 5, 6

Obtain blood cultures and sputum cultures before initiating antibiotics in all hospitalized elderly patients to allow pathogen-directed therapy and de-escalation 1
Ensure adequate oxygenation with monitoring of oxygen saturation, maintaining PaO₂ >8 kPa and SaO₂ >92% 1
Assess volume status and provide IV fluids as needed, as elderly patients are prone to dehydration 1
Monitor vital signs at least twice daily: temperature, respiratory rate, pulse, blood pressure, mental status, and oxygen saturation 1